|
|
|
Volumn 2, Issue 3, 2004, Pages 152-
|
|
In focus: ECOG 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT).
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
RITUXIMAB;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG ADMINISTRATION;
HUMAN;
MULTICENTER STUDY;
NONHODGKIN LYMPHOMA;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LYMPHOMA, NON-HODGKIN;
MULTICENTER STUDIES;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
|
EID: 34548144767
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|